Wordt geladen...
Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?
Aberrant activity of tyrosine kinases has been proved to be associated with multiple diseases including fibrotic diseases. Tyrosine kinases inhibitors (TKIs) might be a novel approach to transform the anti-fibrotic treatment. However, both beneficial and adverse effects are observed by researchers w...
Bewaard in:
| Gepubliceerd in: | Oncotarget |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341902/ https://ncbi.nlm.nih.gov/pubmed/27588502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11767 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|